intracerebr
inocul
theiler
murin
encephalomyel
viru
tmev
suscept
mous
strain
produc
chronic
demyelin
diseas
mononuclear
cellrich
infiltr
central
nervou
system
cn
promin
current
evid
strongli
support
immunemedi
basi
myelin
breakdown
effector
role
propos
tmevspecif
major
histocompat
complex
mhc
class
iirestrict
delayedtyp
hypersensit
dth
respons
lymphokineactiv
macrophag
mediat
bystand
demyelin
present
studi
examin
possibl
concomit
laterappear
neuroantigenspecif
autoimmun
cell
respons
demonstr
chronicrelaps
experiment
allerg
encephalomyel
reae
may
contribut
demyelin
process
follow
tmev
infect
cell
respons
intact
purifi
major
myelin
protein
myelin
basic
protein
mbp
proteohpid
protein
plp
alter
myelin
constitu
readili
demonstr
sjlj
mice
reae
detect
sjlj
mice
tmevinduc
demyehn
diseas
tmevinfect
mice
also
display
cell
respons
peptid
fragment
mbp
plp
recent
shown
encephalitogen
sjlj
mice
addit
induct
neuroantigenspecif
toler
heterogen
mixtur
cn
antigen
via
iv
inject
syngen
sjlj
splenocyt
coval
coupl
mous
spinal
cord
homogen
result
signific
suppress
clinic
histolog
sign
reae
accompani
mbpand
plpspecif
dth
respons
contrast
neuroantigenspecif
toler
fail
alter
develop
clinic
histolog
sign
tmevinduc
demyelin
diseas
accompani
virusspecif
dth
humor
immun
respons
find
demonstr
tmevinduc
demyelin
diseas
occur
appar
absenc
neuroantigenspecif
autoimmun
respons
relationship
present
result
immunopatholog
multipl
sclerosi
discuss
follow
intracerebr
ic
inocul
theiler
murin
encephalomyel
virus
tmev
certain
mous
strain
develop
chronic
inflammatori
demyelin
diseas
begin
month
postinfect
pi
lipton
dal
canto
lipton
lehrich
et
al
patholog
process
relat
persist
infect
wherein
low
level
viru
recov
central
nervou
system
cn
virtual
lifetim
mous
lipton
lehrich
et
al
lipton
et
al
recent
propos
model
clatch
et
al
wherein
virusspecif
delayedtyp
hypersensit
dth
within
cn
result
demyelin
termin
nonspecif
bystand
respons
mediat
activ
macrophag
hypothesi
base
recent
studi
show
diseas
suscept
correl
tempor
develop
chronic
high
level
tmevspecif
major
histocompat
complex
mhc
class
iirestrict
dth
respons
virusspecif
serum
antibodi
splenic
cell
prohfer
tprlf
respons
cn
viru
titer
clatch
et
al
clatch
et
al
clatch
et
al
hypothesi
would
account
characterist
mononuclear
cellrich
infiltr
observ
area
primari
demyelin
dal
canto
lipton
lehrich
et
al
increas
number
macrophag
tmev
appear
primarili
persist
within
cn
dal
canto
lipton
rodriguez
et
al
hypothesi
also
consist
previou
find
suscept
tmevinduc
demyelin
diseas
control
least
two
unlink
gene
one
map
mhc
clatch
et
al
clatch
et
al
rodriguez
david
rodriguez
et
al
anoth
close
link
constant
region
gene
encod
flchain
cell
receptor
melvold
et
al
tmevinduc
demyelin
diseas
consid
one
best
experiment
anim
model
multipl
sclerosi
ms
due
histopatholog
genet
similar
epidemiolog
studi
favor
viral
etiolog
ms
nathanson
miller
kurtk
hyllest
due
histopatholog
similar
experiment
allerg
encephalomyel
eae
possibl
role
autoimmun
neuroantigenspecif
cellmedi
immun
cmi
respons
hypothes
ms
waksman
one
could
also
envis
autoimmun
mechan
contribut
demyelin
process
follow
tmev
infect
direct
consequ
cn
viru
infect
b
secondari
tmevspecif
immunemedi
cn
damag
c
result
crossreact
tmev
cn
antigen
ie
molecular
mimicri
previou
studi
support
role
autoimmun
respons
myelin
antigen
tmevinduc
demyehn
diseas
neuroantigenspecif
cmi
respons
major
myelin
protein
myelin
basic
protein
mbp
proteohpid
protein
plp
detect
tmevinfect
sjlj
mice
miller
et
al
contrast
respons
easili
demonstr
mice
chronicrelaps
eae
reae
kennedi
et
al
miller
et
al
howev
previou
studi
examin
cell
respons
specif
encephalitogen
region
mbp
plp
exclud
possibl
role
autoimmun
respons
minor
myelin
compon
alter
myelin
antigen
nonmyelinassoci
cn
antigen
present
studi
examin
mice
tmevinduc
demyelin
diseas
fail
reveal
cell
respons
specif
defin
encephalitogen
peptid
either
mbp
kono
et
al
plp
tuohi
et
al
spinal
cord
homogen
fraction
contain
heterogen
mixtur
myelin
nonmyelinassoci
cn
antigen
addit
induct
neuroantigenspecif
immun
toler
sjlj
mice
via
iv
inject
syngen
splenocyt
coval
coupl
crude
mous
spinal
cord
homogen
mschsp
kennedi
et
al
effect
develop
tmevspecif
cmi
respons
clinic
histolog
sign
tmevinduc
demyelin
diseas
sever
inhibit
induct
clinic
histolog
reae
accompani
neuroantigenspecif
autoimmun
respons
result
demonstr
chronic
tmevinduc
demyelin
occur
appar
absenc
neuroantigenspecif
autoimmun
respons
femal
sjlj
mice
week
old
purchas
jackson
laboratori
bar
harbor
usa
mice
hous
northwestern
anim
care
facil
except
period
sever
paralysi
maintain
standard
laboratori
chow
water
ad
libitum
sever
paralyz
mice
afford
easier
access
food
water
within
experi
mice
agematch
week
shipment
plaqu
purif
work
stock
bean
strain
tmev
prepar
passag
cell
viru
purifi
isopycn
centrifug
gradient
lipton
friedman
mous
myelin
basic
protein
mous
mbp
prepar
purifi
accord
method
swanborg
et
al
watersolubl
human
proteolipid
apoprotein
hu
plp
prepar
purifi
accord
method
lee
sakura
synthet
peptid
murin
plp
hslgkwlghpdkf
contain
serin
cystein
substitut
residu
tuohi
murin
mbp
vtprtpppsqgkgr
kono
et
al
shown
encephalitogen
sjlj
mous
prepar
simultan
multipl
peptid
synthesi
teabag
method
houghten
et
al
houghten
et
al
exactli
previous
describ
tuohi
lyophil
prepar
mous
spinal
cord
homogen
msch
prepar
follow
homogen
freshli
obtain
sjlj
spinal
cord
distil
water
prior
use
dth
tprlf
assay
msch
suspens
mgml
pb
sonic
min
branson
sonic
water
bath
subject
r
irradi
sourc
erythrocytefre
splenocyt
coupl
nonson
msch
use
ecdicoupl
procedur
miller
et
al
briefli
salinewash
sjlj
splenocyt
pellet
ml
centrifug
tube
resuspend
final
concentr
x
cellsml
salin
contain
mgml
msch
shamcoupl
call
prepar
without
msch
reaction
mixtur
coupl
reaction
initi
addit
ml
freshli
prepar
carbodiimid
mgml
salin
calbiochembehr
corp
la
jolla
ca
usa
per
ml
cell
suspens
final
concentr
carbodiimid
mgml
follow
h
incub
c
cell
wash
time
balanc
salt
solut
bss
maintain
use
toler
induc
iv
inject
mschcoupl
splenocyt
mschsp
ml
bss
mice
toler
day
rel
immun
day
sevento
mice
immun
msch
complet
freund
adjuv
hereaft
refer
mschcfa
day
accord
method
brown
mcfarlin
slight
modif
previous
describ
kennedi
et
al
mice
observ
clinic
sign
diseas
everi
day
score
accord
clinic
sever
follow
grade
abnorm
grade
limp
tail
grade
limp
tail
hind
limb
weak
waddl
gait
grade
partial
hind
limb
paralysi
grade
complet
hind
limb
paralysi
grade
moribund
clinic
relaps
score
mous
develop
new
neurolog
deficit
increas
clinic
sever
least
grade
period
stabil
improv
clinic
score
sjlj
mice
immun
sc
tail
base
purifi
uvinactiv
tmev
plp
g
mbp
ml
cfa
emuls
sevento
sjlj
femal
mice
anesthet
methoxyfluran
inocul
right
cerebr
hemispher
x
plaqueform
unit
pfu
stock
bean
viru
control
mice
receiv
dulbecco
modifi
earl
medium
dmem
anim
examin
sever
time
per
week
develop
neurolog
sign
particularli
chronic
gait
abnorm
indic
tmevinduc
demyelin
lipton
dal
canto
found
clinic
diseas
endpoint
reliabl
marker
sever
demyelin
diseas
clatch
et
al
clatch
et
al
two
four
mice
per
experiment
group
anesthet
sodium
pentobarbit
sacrif
total
bodi
perfus
left
ventricl
chill
glutaraldehyd
phosphat
buffer
ph
spinal
cord
remov
dissect
cut
mm
thick
crosssect
postfix
oso
dehydr
embed
epon
previous
describ
dal
canto
lipton
toluidin
bluestain
section
segment
per
mous
read
blindli
dth
respons
elicit
mice
reae
day
first
inject
mschcfa
tmevinfect
mice
day
pi
day
postprim
mice
peripher
immun
uvinactiv
tmev
encephalitogen
peptid
plp
mbp
respons
quantit
use
ear
swell
assay
previous
describ
clatch
et
al
prechalleng
ear
thick
determin
use
mitutoyo
model
engin
micromet
schlesing
tool
brooklyn
ny
usa
immedi
thereaft
dth
respons
elicit
inject
sonic
spinal
cord
homogen
g
mous
mbp
mbp
human
plp
plp
uvinactiv
tmev
salin
dorsal
surfac
ear
use
hamilton
syring
fit
needl
h
challeng
increas
ear
thick
prechaueng
measur
determin
result
express
unit
inch
ear
swell
respons
result
mononuclear
cell
infiltr
show
typic
dth
kinet
ie
minim
swell
h
maxim
swell
h
follow
dth
measur
spleen
mice
inocul
ic
viabl
viru
drain
lymph
node
cell
reae
mice
mice
peripher
immun
uvinactiv
tmev
encephalitogen
neuroantigen
peptid
pool
cultur
vitro
previous
describ
determin
antigenspecif
tprlf
respons
clatch
et
al
x
viabl
cell
cultur
h
flatbottom
microwel
plate
ml
modifi
click
medium
corradin
et
al
contain
x
supplement
fresh
syngen
mous
serum
cultur
stimul
gwell
uvinactiv
tmev
plp
plp
mbp
mbp
gwell
sonic
spinal
cord
homogen
cultur
puls
ci
thymidin
tdr
cimmol
research
product
intern
corp
mount
prospect
il
usa
final
h
cultur
harvest
onto
glass
fiber
filter
autom
sampl
harvest
radioact
measur
trichloroacet
acid
tca
insolubl
materi
determin
beckman
liquid
scintil
counter
cultur
run
triplic
result
express
delta
count
per
minut
zacpm
mean
cpm
stimul
cultur
mean
cpm
control
cultur
stimul
indic
mean
cpm
stimul
cultur
mean
cpm
control
cultur
prolif
respons
condit
shown
iarestrict
mediat
cell
clatch
et
al
kennedi
et
al
serum
antibodi
level
bean
strain
tmev
quantit
use
modifi
particl
concentr
fluoresc
immunoassay
pcfia
previous
describ
peterson
et
al
briefli
assay
perform
fluid
phase
allow
bind
serial
dilut
serum
antibodi
fluorescein
isothiocyan
fitc
label
tmev
result
antibodyantigen
complex
captur
solidphas
matrix
consist
affinitypurifi
goat
antimous
igcoat
polystyren
particl
unbound
immunoglobulin
remov
wash
solidphaseassoci
fluoresc
concentr
bottom
assay
well
measur
rel
fluoresc
unit
rfu
antibodi
concentr
mgml
determin
logarithm
linear
regress
analysi
serial
dilut
curv
comparison
hyperimmun
serum
standard
statist
signific
dth
serum
antibodi
respons
experiment
group
analyz
use
onetail
analysi
anc
group
mean
compar
use
multipl
comparison
test
armitag
comparison
percentag
anim
show
clinic
diseas
two
group
mice
analyz
x
p
valu
consid
signific
previou
studi
indic
tmevinfect
mice
fail
exhibit
dth
tprlf
respons
upon
challeng
purifi
major
myelin
protein
mbp
plp
respons
detect
mice
reae
miller
et
al
determin
whether
potenti
antimyelin
respons
may
gone
undetect
due
insuffici
molar
concentr
relev
encephalitogen
epitop
upon
challeng
intact
myelin
protein
mice
three
per
group
infect
viabl
tmev
peripher
immun
uvinactiv
tmev
emulsifi
cfa
challeng
encephalitogen
peptid
plp
mbp
seen
fig
sjlj
mice
infect
tmev
day
pi
mice
peripher
immun
tmev
exhibit
signific
dth
left
panel
tprlf
respons
fight
panel
upon
challeng
uvinactiv
tmev
fail
respond
plp
mbp
encephalitogen
peptid
similar
result
seen
mice
infect
tmev
day
previous
control
sjlj
mice
immun
g
plp
four
per
group
respond
significantli
challeng
homolog
plp
peptid
intact
plp
fail
respond
tmev
mbp
similarli
mice
immun
g
mbp
three
per
group
respond
weakli
significantli
challeng
mbp
respond
challeng
tmev
plp
data
confirm
earlier
report
show
lack
cell
respons
specif
intact
mbp
plp
tmevinfect
mice
indic
lack
sponsiv
high
concentr
encephalitogen
epitop
mbp
plp
address
possibl
role
autoimmun
respons
minor
myelin
compon
alter
myelin
antigen
nonmyelinassoci
cn
antigen
pathogenesi
tmevinduc
demyelin
diseas
next
ask
tmevinfect
mice
exhibit
cell
respons
spinal
cord
homogen
fraction
contain
heterogen
mixtur
myelin
nonmyelinassoci
cn
antigen
homogen
prepar
spinal
cord
normal
mice
normal
msch
spinal
cord
mice
undergo
activ
reae
eae
msch
tmevinduc
demyelin
diseas
tmev
msch
test
latter
two
prepar
use
attempt
determin
tmevinfect
mice
would
respond
neuroantigen
determin
might
modifi
alter
consequ
activ
immunemedi
demyelin
seen
fig
mice
three
per
group
infect
tmev
day
previous
fail
respond
either
dth
tprlf
respons
challeng
mbp
msch
prepar
panel
b
contrast
mice
per
group
sensit
mschcfa
panel
respond
vigor
challeng
mbp
well
msch
prepar
thu
mice
undergo
activ
tmevinduc
demyelin
diseas
fail
respond
heterogen
mixtur
myelin
nonmyelinassoci
cn
antigen
deriv
either
normal
damag
spinal
cord
tissu
recent
report
kennedi
et
al
histopatholog
reae
induc
sc
inject
mschcfa
inhibit
clinic
reae
follow
mschsp
toler
correl
induct
antigenspecif
toler
dth
two
major
myelin
protein
mbp
plp
test
hypothesi
neuroantigenspecif
autoimmun
respons
may
play
contributori
role
pathogenesi
tmevinduc
demyelin
diseas
ask
neuroantigenspecif
toler
msch
protein
contain
heterogen
mixtur
neuroantigen
would
affect
develop
clinic
sign
tmevinduc
demyelin
two
separ
experi
total
sjlj
mice
inject
shamcoupl
spleen
cell
shamsp
mice
mschsp
day
day
mice
treatment
group
immun
msch
cfa
observ
develop
clinic
reae
day
fig
remain
mice
treatment
group
inocul
ic
viru
observ
clinic
sign
tmevinduc
demyelin
diseas
day
fig
agreement
recent
result
kennedi
et
al
iv
toler
mschsp
led
signific
p
decreas
clinic
reae
affect
compar
control
inject
shamsp
affect
averag
clinic
score
affect
mice
shamspinject
group
sever
affect
mice
one
die
one
recov
complet
remain
chronic
affect
six
exhibit
clinic
relaps
averag
clinic
score
affect
mschspinject
mice
gener
less
sever
shamtoler
control
affect
anim
complet
recov
initi
clinic
episod
contrast
suppress
reae
neuroantigenspecif
toler
effect
develop
clinic
sign
tmevinduc
demyelin
diseas
fig
microscop
examin
spinal
cord
day
shamtoler
mice
sensit
mschcfa
show
classic
featur
murin
eae
diseas
character
presenc
inflammatori
infiltr
surround
area
demyelin
well
axon
destruct
fig
contrast
anim
toler
mschsp
day
prior
sensit
mschcfa
devoid
demyelin
lesion
occasion
small
number
mononuclear
cell
observ
around
mening
vessel
fig
flammatori
demyelin
lesion
characterist
viral
infect
fig
previous
shown
onset
initi
clinic
sign
reae
correl
develop
mbpand
plpspecif
mhc
class
iirestrict
dth
respons
kennedi
et
al
determin
inhibit
clinic
sign
demyelin
mschsptoler
mschcfaprim
mice
correl
induct
neuroantigenspecif
cell
toler
mice
use
assess
clinic
sign
test
day
dth
reactiv
mbp
plp
seen
fig
mice
inject
iv
mschsp
exhibit
significantli
suppress
mbpand
plpspecif
dth
respons
compar
shamspinject
control
thu
result
confirm
earlier
observ
inhibit
clinic
reae
follow
neuroantigenspecif
toler
induct
correl
abrog
neuroantigenspecif
dth
reactiv
kennedi
et
al
contrast
neuroantigenspecif
toler
induct
affect
level
tmevspecif
dth
splenic
cell
prolif
respons
tmevinfect
anim
fig
similarli
tmevspecif
serum
antibodi
respons
measur
pcfia
assay
similar
p
sham
mgml
mschsptoler
mgml
mice
data
shown
fig
test
antigenspecif
dth
andor
splenic
cell
prolif
respons
panel
eight
shamspand
eight
mschsptoler
mice
test
nenroantigenspecif
dth
respons
day
rel
mschcfa
sensit
day
ear
challeng
g
mous
mbp
left
ear
open
bar
g
human
plp
right
ear
solid
bar
result
express
h
ear
swell
respons
background
respons
neg
control
mice
subtract
unit
inch
sem
background
ear
swell
respons
unimmun
mice
mous
mbp
human
plp
asterisk
indic
respons
significantli
differ
p
correspond
respons
shamsptoler
control
percent
suppress
dth
respons
mschsptoler
mice
rel
shamtoler
control
indic
parenthes
panel
b
seven
shamsptoler
mice
eight
mschsptoler
mice
test
tmevspecif
cmi
dth
splenic
tprlf
respons
day
pi
dth
elicit
ear
challeng
g
uvinactiv
tmev
result
express
h
ear
swell
respons
background
respons
neg
control
mice
subtract
unit
inch
sem
background
ear
swell
five
unimmun
mice
unit
follow
h
ear
measur
mice
group
sacrif
viabl
spleen
cell
cultur
current
evid
strongli
suggest
immunemedi
basi
myelin
breakdown
tmevinduc
demyelin
diseas
evid
includ
studi
show
clinic
sign
tmevinduc
demyelin
diseas
inhibit
immunosuppress
agent
lipton
dal
canto
roo
et
al
vivo
administr
monoclon
antibodi
ia
antigen
rodriguez
et
al
friedmann
et
al
determin
welsh
et
al
sd
miller
et
al
unpublish
base
correl
suscept
demyelin
diseas
develop
high
level
mhc
class
iirestrict
tmevspecif
dth
clatch
et
al
clatch
et
al
clatch
et
al
propos
model
clatch
et
al
wherein
tmevspecif
effector
tdh
cell
play
central
role
cn
demyehn
accord
hypothesi
local
lymphokin
product
virusspecif
tdh
cell
within
cn
effect
recruit
accumul
activ
macrophag
mediat
termin
nonspecif
bystand
respons
result
strip
myelin
lamella
wisnewski
bloom
addit
virusspecif
cmi
also
possibl
autoimmun
cmi
effector
compon
demonstr
eae
could
contribut
demyelin
process
activ
neuroantigenspecif
cmi
respons
could
occur
consequ
cn
viral
infect
via
least
three
mechan
first
viral
replic
could
lead
alter
neuroantigen
metabol
subsequ
releas
nativ
alter
cn
antigen
either
local
peripheri
result
autosensit
within
cn
may
influenc
inappropri
present
self
antigen
cn
astrocyt
londei
et
al
induc
express
nonphysiolog
level
ia
antigen
fontana
et
al
second
virusspecif
immunemedi
damag
may
similarli
lead
releas
neg
alter
cn
antigen
subsequ
autosensit
support
first
two
possibl
sensit
mbp
shown
accompani
two
differ
cn
viral
infect
lymphocyt
rat
subacut
demyelin
encephalomyel
induc
ic
infect
coronaviru
jhm
stimul
prolifer
vitro
respons
mbp
furthermor
adopt
transfer
cell
normal
recipi
led
mild
clinic
diseas
cn
lesion
resembl
eae
watanab
et
al
similarli
cell
line
specif
mbp
isol
rat
subacut
measl
encephalomyel
transfer
eaelik
symptom
normal
recipi
liebert
et
al
howev
appar
crossreact
either
mbpspecif
cell
serum
antibodi
measl
viru
demonstr
third
mechan
lead
autosensit
could
occur
virusspecif
immun
respons
crossreact
antigen
determin
normal
express
cn
tissu
ie
molecular
mimicri
notkin
et
al
oldston
notkin
support
molecular
mimicri
approxim
monoclon
antivir
antibodi
shown
crossreact
host
determin
express
uninfect
tissu
srinivasappa
et
al
similarli
potenti
crossreact
antigen
capabl
stimul
cmi
respons
identifi
sequenc
homolog
viral
structur
protein
synthet
peptid
composit
base
area
sequenc
homolog
hepat
b
viru
polymeras
encephalitogen
region
rabbit
mbp
report
induc
mild
perivascular
infiltr
cn
reminisc
eae
rabbit
peptid
also
induc
humor
cmi
respons
crossreact
mbp
fujinami
oldston
contrast
jhm
measl
viru
model
previou
studi
support
role
neuroantigenspecif
autoimmun
respons
tmevinduc
demyelin
diseas
neither
clinic
histopatholog
sign
demyelin
transfer
serum
lymphoid
cell
tmevinfect
donor
normal
nontmevinfect
recipi
suggest
lack
neuroantigenspecif
autoimmun
respons
barbano
dal
canto
addit
serum
lymphoid
cell
tmevinfect
donor
fail
injur
myelin
isogen
organotyp
cultur
vitro
barbano
dal
canto
direct
measur
neuroantigenspecif
dth
splenic
tprlf
respons
specif
major
myelin
protein
mbp
plp
detect
sjlj
mice
time
follow
ic
inocul
tmev
miller
et
al
includ
time
point
prior
onset
clinic
sign
diseas
day
pi
shortli
onset
diseas
day
pi
week
onset
diseas
day
pi
contrast
mbpand
plpspecif
dth
tprlf
respons
readili
demonstr
sjlj
mice
directli
first
appear
clinic
reae
day
immun
mschcfa
indic
cm
respons
myelin
compon
readili
detect
mice
reae
kennedi
et
al
miller
et
al
addit
peripher
immun
sjlj
mice
either
uvinactiv
tmev
rat
mbp
emulsifi
cfa
fail
reveal
crossreact
cmi
respons
upon
secondari
stimul
prime
lymph
node
cell
vitro
miller
et
al
lack
neuroantigen
reactiv
tmevinfect
mice
measur
function
cmi
analys
support
absenc
signific
amino
acid
ident
tmev
capsid
protein
mbp
plp
miller
et
al
thu
data
consist
hypothesi
clatch
et
al
clatch
et
al
tmevspecif
cmi
respons
constitut
major
effector
mechan
cn
demyelin
follow
tmev
infect
lack
reactiv
major
myelin
protein
confirm
present
report
addit
present
data
fig
fail
demonstr
cell
respons
specif
determin
plp
tuohi
et
al
mbp
kono
et
al
recent
shown
encephalitogen
sjlj
mice
failur
mbp
vtprtpppsqgkgr
elicit
respons
tmevinfect
sjlj
mice
particularli
relev
rtppp
pentapeptid
sequenc
contain
within
peptid
correspond
area
sequenc
homolog
mous
mbp
tmev
polyprotein
map
nonstructur
protein
tmev
miller
et
al
although
previou
data
support
major
role
class
iirestrict
autoimmun
cell
respons
mbp
plp
tmevinduc
demyelin
process
could
exclud
possibl
role
autoimmun
respons
minor
myelin
compon
myelinassoci
glycoprotein
myelin
oligodendrocyt
glycoprotein
galactocerebrosid
rapport
et
al
quarl
et
al
linington
lassmann
alter
neuroantigen
determin
nonmyelinassoci
neuroantigen
attempt
address
possibl
employ
two
differ
experiment
approach
first
ask
mice
tmevinduc
demyelin
diseas
exhibit
cell
respons
spinal
cord
homogen
fraction
contain
heterogen
mixtur
myelin
nonmyelinassoci
cn
antigen
homogen
prepar
spinal
cord
normal
mice
mice
undergo
activ
reae
tmevinduc
demyelin
diseas
might
expect
contain
neuroantigen
determin
modifi
alter
consequ
activ
immunemedi
demyelin
stimul
cell
respons
mice
reae
tmevinfect
mice
fig
next
determin
effect
induc
neuroantigenspecif
toler
cours
tmevinduc
demyelin
diseas
splenocyt
coval
coupl
mous
spinal
cord
homogen
use
induc
specif
toler
heterogen
mixtur
cn
antigen
studi
laboratori
shown
specif
inhibit
dth
antibodi
respons
occur
follow
iv
inject
antigencoupl
syngen
splenocyt
miller
claman
bach
et
al
green
et
al
miller
et
al
via
clonal
inhibit
cell
activ
antigenspecif
suppressor
cell
miller
et
al
previous
shown
kennedi
et
al
mschsptoler
mice
fail
develop
neuroantigenspecif
dth
respons
significantli
reduc
incid
clinic
histolog
sign
reae
least
week
toler
present
result
confirm
previou
find
regard
abil
mschspinduc
toler
adult
immunocompet
mice
significantli
suppress
develop
reae
causal
mbpand
plpspecif
dth
respons
contrast
data
show
neuroantigenspecif
toler
fail
affect
develop
clinic
histolog
sign
demyelin
diseas
accompani
virusspecif
cmi
antibodi
respons
induc
tmev
infect
fig
thu
present
result
confirm
extend
nonquantit
result
lang
et
al
show
treatment
immunoincompet
neonat
sjlj
mice
msch
incomplet
freund
adjuv
fail
affect
develop
demyelin
lesion
cn
follow
infect
da
strain
tmev
sinc
toler
regimen
involv
use
heterogen
mixtur
neuroantigen
ie
msch
like
cellmedi
immun
respons
neuroantigen
minor
undefin
encephalitogen
potenti
toler
addit
dth
respons
mbp
plp
probabl
lack
respons
minor
neuroantigen
tmevinduc
demyelin
diseas
support
observ
cmi
respons
whole
msch
demonstr
mice
reae
tmevinfect
mice
fig
emphas
present
result
address
lack
neuroantigenspecif
autoimmun
respons
earli
stage
day
pi
tmevinduc
demyelin
current
determin
whether
induct
neuroantigenspecif
toler
first
appear
clinic
sign
demyelin
effect
chronic
cours
diseas
would
interest
appli
current
methodolog
neuroantigenspecif
toler
induct
determin
mbpspecif
immun
respons
play
primari
secondari
patholog
role
subacut
demyelin
observ
rat
infect
jhm
watanab
et
al
measl
liebert
et
al
virus
feel
present
previou
result
suggest
chronic
demyelin
occur
appar
absenc
neuroantigenspecif
autoimmun
respons
consist
propos
hypothesi
tmevspecif
cmi
respons
major
effector
mechan
cn
demyelin
follow
tmev
infect
clatch
et
al
clatch
et
al
current
result
may
particularli
applic
ms
circumstanti
evid
favor
viral
etiolog
nathanson
miller
kurtk
hyllest
lack
convinc
evid
ms
patient
display
elev
humor
cmi
respons
major
encephalitogen
neuroantigen
mbp
plp
waksman
waksman
reynold
rain
hafler
et
al
futur
studi
tmevinduc
demyelin
diseas
model
examin
whether
induct
specif
toler
tmev
antigen
prevent
alter
cours
diseas
